We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Seaman, in terms of saying ‘news soon’, this is not my subjective opinion. The FDA will grant or decline approval imminently. It is with the FDA (the assessment process cannot go on indefinitely).
Hi d.Monies . Salarius and Lucyd have been brought to market ....if belluscura is approved , that will be the third portfolio brought from concept to commercial reality. There is uncertainty of future success (none of the portfolios have had a break through in terms of financial success) .
I have faith in the integrity of the management , not that this guarantees success. You seem to be suggesting otherwise , with the ‘suspect’ reference. I can’t imagine holding my investment in those circumstances, even if selling at a loss .
Good luck all
It's a portable Oxygen tank, it's going to take some rigid testing, not sure how a company with a product currently with the FDA is a "dead duck" I'd say it's more on the brink of commercial success (all going well). Looks like people getting impatient. I'll grab some more if they knock it down further. GLA
"What is the sense in criticising announcements made in 2018?" It's quite straight forward, TEK & Belluscura are starting to look like bulls***ers, you can only keep spinning a yarn for so long - eventually you have to come up with the goods and TEK never does but Cliff keeps getting paid his salary though. I'd go as far as to say Dr Clifford Gross and Robert Rauker are starting to look a bit suspect, what kind of deal have they got going ? And for anyone itching to get a "why are you still invested then" response in, the way things are going i'll be out soon as I'm not prepared to go back into negative territory here with this one. Very poor show.
At the end of the day this is a chat board and we all have opinions which is good , I'm certainly no expert but I'm afraid the endless delays have led me to discount Belluscura as being a goer , that's the way I feel and see huge future potential in Guidant . You cant just keep saying we will know soon or news very soon as it just feels very poor to me. Honestly feel like Lucyd will pull more interest here than Belluscura as people are losing faith with endless promises that are missed . As I say it's my opinion only
It not rational to say belluscura is a dead duck based on the current delay.
The share price will be +50% (that’s very conservative) if approval granted.
Hard for any sensible investor to dismiss this potential increase as meaningless.
The product is with FDA and so until there is news to the contrary, further delays would seem to be
out of belluscura’s Control.
It is only a dead duck if you think it will never get FDA approval or if given approval, you think it won’t be able to successfully penetrate the market. FDA approval is more likely than not and even if they can’t penetrate the market , the intellectual property has value.
As is often the case on here , missed dead lines are referred to as something that relates to pure incompetence. In my personal view, this is to misunderstand the nature of technological development. There are delays and bumps in the road when producing new technology / products.
When producing anything new , there is always an unknown element in terms of time .
You can’t directly compare it to the more structured delivery time table than may be more relevant to other products and sectors . In my personal experience, I have seen millions spent on IT Infrastructure , only for those projects to be abandoned totally (by large blue chip companies - after years of development ).
TEK May have been overly optimistic in the past in terms of delivery dates . But , as investors, what is the sense in criticising announcements made in 2018? The SP is a reflection of the here and now not 2018. The current SP reflects missed dead lines and lack of news .
As is always the case with start ups , there is uncertainty around every corner. But, in terms of belluscura we should know very soon. I would suggest a prospective evaluation is the way forward (not revisiting historical failures - unless you genuinely believe these failures are indicative of the future - in which case why are you invested here ?)
GLA
What, in your opinion Seaman, makes you think its a "dead duck"?
Belluscura have a very professional website, regular twitter updates and TEK have RNS'd the FDA approval process, albeit some time ago.
Iv got very positive thoughts on Guidant but Belluscura are a dead duck I'm afraid imho, they are clearly useless another 8 weeks from the potential approval and no news
"In a consumer update, @US_FDA You may have seen #oxygen concentrators for sale online without a prescription. At this time, the FDA has not approved or cleared any oxygen concentrators to be sold or used without a prescription. https://t.co/Dq6XD1QVIg"
Can't understand why its taken so long for an FDA decision.